These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 10464725)
1. Onychomycosis: a compendium of facts and a clinical experience. Schlefman BS J Foot Ankle Surg; 1999; 38(4):290-302. PubMed ID: 10464725 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. Gupta AK; Gregurek-Novak T Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230 [TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. Gupta AK J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137 [TBL] [Abstract][Full Text] [Related]
4. The new oral antifungal agents for onychomycosis of the toenails. Gupta AK; Shear NH J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624 [TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis. Gupta AK Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650 [TBL] [Abstract][Full Text] [Related]
6. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Gupta AK; Shear NH Drug Saf; 2000 Jan; 22(1):33-52. PubMed ID: 10647975 [TBL] [Abstract][Full Text] [Related]
7. A questionnaire study on the management of onychomycosis: a Canadian perspective. Gupta AK; Shear NH Int J Dermatol; 1998 Jun; 37(6):457-60. PubMed ID: 9646138 [TBL] [Abstract][Full Text] [Related]
8. Oral therapeutic agents in fungal nail disease. Roberts DT J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S78-81. PubMed ID: 8077514 [TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model. Marchetti A; Piech CT; McGhan WF; Neugut AI; Smith BT Clin Ther; 1996; 18(4):757-77; discussion 702. PubMed ID: 8879902 [TBL] [Abstract][Full Text] [Related]
10. Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy. Elewski BE; Hay RJ Clin Infect Dis; 1996 Aug; 23(2):305-13. PubMed ID: 8842269 [TBL] [Abstract][Full Text] [Related]
11. Terbinafine: a review of its use in onychomycosis in adults. Darkes MJ; Scott LJ; Goa KL Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372 [TBL] [Abstract][Full Text] [Related]
13. Oral therapy for onychomycosis: an evidence-based review. de Sá DC; Lamas AP; Tosti A Am J Clin Dermatol; 2014 Feb; 15(1):17-36. PubMed ID: 24352873 [TBL] [Abstract][Full Text] [Related]
14. Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis. Del Rosso JQ J Am Osteopath Assoc; 1997 Jun; 97(6):339-46. PubMed ID: 9232944 [TBL] [Abstract][Full Text] [Related]
15. Current trends in onychomycosis therapy: a literature review. Hecker D Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835 [TBL] [Abstract][Full Text] [Related]
17. New therapies for onychomycosis. Odom RB J Am Acad Dermatol; 1996 Sep; 35(3 Pt 2):S26-30. PubMed ID: 8784308 [TBL] [Abstract][Full Text] [Related]
18. [Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine]. Bergman W; Rutten FF Ned Tijdschr Geneeskd; 1994 Nov; 138(47):2346-50. PubMed ID: 7969635 [TBL] [Abstract][Full Text] [Related]